Cargando…

Cyclin-Dependent Kinase Inhibitor 3 Promotes Cancer Cell Proliferation and Tumorigenesis in Nasopharyngeal Carcinoma by Targeting p27

Nasopharyngeal carcinoma (NPC) is a common malignancy of the head and neck that arises from the nasopharynx epithelium and is highly invasive. Cyclin-dependent kinase inhibitor 3 (CDKN3) belongs to the dual-specificity protein phosphatase family, which plays a key role in regulating cell division. A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Huimin, Chen, Hexin, Zhou, Hang, Yu, Wenfa, Lu, Zhenmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cognizant Communication Corporation 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840971/ https://www.ncbi.nlm.nih.gov/pubmed/28109073 http://dx.doi.org/10.3727/096504017X14835311718295

Ejemplares similares

Expression of cyclin-dependent kinase inhibitor p27kip1 in malignant lymphomas.
por: Oh, Y. H., et al.
Publicado: (2000)

The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancer
por: Chiarle, Roberto, et al.
Publicado: (2001)

Doxycycline Regulated Induction of AKT in Murine Prostate Drives Proliferation Independently of p27 Cyclin Dependent Kinase Inhibitor Downregulation
por: Wang, Hongyun, et al.
Publicado: (2012)

Protein Phosphatase 1H, Cyclin-Dependent Kinase Inhibitor p27, and Cyclin-Dependent Kinase 2 in Paclitaxel Resistance for Triple Negative Breast Cancers
por: Hur, Saem, et al.
Publicado: (2020)

Cardiac differentiation in Xenopus requires the cyclin-dependent kinase inhibitor, p27Xic1
por: Movassagh, Mehregan, et al.
Publicado: (2008)

E-Cadherin–dependent Growth Suppression is Mediated by the Cyclin-dependent Kinase Inhibitor p27(KIP1)
por: St. Croix, Brad, et al.
Publicado: (1998)

PCAF regulates the stability of the transcriptional regulator and cyclin-dependent kinase inhibitor p27(Kip1)
por: Pérez-Luna, Maria, et al.
Publicado: (2012)

Reduced Expression of Cyclin–dependent Kinase Inhibitor p27(Kipl) Is Associated with Advanced Stage and Invasiveness of Gastric Carcinomas
por: Yasui, Wataru, et al.
Publicado: (1997)

The Renaissance of Cyclin Dependent Kinase Inhibitors
por: Ettl, Tobias, et al.
Publicado: (2022)

Cyclin-Dependent Kinase Inhibitor P27(Kip1) Is Required for Mouse Mammary Gland Morphogenesis and Function
por: Muraoka, Rebecca S., et al.
Publicado: (2001)

Upregulation of p27 cyclin-dependent kinase inhibitor and a C-terminus truncated form of p27 contributes to G1 phase arrest
por: Satoh, Takayuki, et al.
Publicado: (2016)

Accelerated turnover of taste bud cells in mice deficient for the cyclin-dependent kinase inhibitor p27(Kip1)
por: Harrison, Theresa A, et al.
Publicado: (2011)

Editor's Note on ‘PCAF regulates the stability of the transcriptional regulator and cyclin-dependent kinase inhibitor p27(Kip1)’
Publicado: (2023)

Cyclin-dependent kinase inhibitors in malignant hematopoiesis
por: Schirripa, Alessia, et al.
Publicado: (2022)

MicroRNA-195-3p inhibits cyclin dependent kinase 1 to induce radiosensitivity in nasopharyngeal carcinoma
por: Xie, Fuchuan, et al.
Publicado: (2021)

Cyclin-Dependent Kinase 2 Promotes Tumor Proliferation and Induces Radio Resistance in Glioblastoma
por: Wang, Jia, et al.
Publicado: (2016)

Cyclin-Dependent Kinase Inhibitor p27(Kip1) Controls Growth and Cell Cycle Progression in Human Uterine Leiomyoma
por: Ramachandran, Sabarish, et al.
Publicado: (2008)

Cyclin-dependent kinase inhibitors p21 and p27 function as critical regulators of liver regeneration following 90% hepatectomy in the rat
por: Moniaux, Nicolas, et al.
Publicado: (2020)

miR-592 acts as an oncogene and promotes medullary thyroid cancer tumorigenesis by targeting cyclin-dependent kinase 8
por: Liu, Ting, et al.
Publicado: (2020)

miR-592 acts as an oncogene and promotes medullary thyroid cancer tumorigenesis by targeting cyclin-dependent kinase 8
por: Liu, Ting, et al.
Publicado: (2021)

Regulation of expression by promoters versus internal ribosome entry site in the 5′-untranslated sequence of the human cyclin-dependent kinase inhibitor p27(kip1)
por: Liu, Zhaoqian, et al.
Publicado: (2005)

Role of Cyclin-Dependent Kinase Inhibitors in Endometrial Cancer
por: Giannone, Gaia, et al.
Publicado: (2019)

Inhibitors of Cyclin-Dependent Kinases: Types and Their Mechanism of Action
por: Łukasik, Paweł, et al.
Publicado: (2021)

Cyclin-dependent kinases
por: Malumbres, Marcos
Publicado: (2014)

Hypoxia Promotes Vascular Smooth Muscle Cell Proliferation through microRNA-Mediated Suppression of Cyclin-Dependent Kinase Inhibitors
por: Lee, Jihui, et al.
Publicado: (2019)

Deregulation of the cyclin-dependent kinase inhibitor p27 as a putative candidate for transformation in Chlamydia trachomatis infected mesenchymal stem cells
por: Abu-Lubad, Mohammad A., et al.
Publicado: (2023)

Plant casein kinases phosphorylate and destabilize a cyclin-dependent kinase inhibitor to promote cell division
por: Qu, Li, et al.
Publicado: (2021)

Expression of Cyclin‐dependent Kinase Inhibitor p27/Kipl and AP‐1 Coactivator p38/Jabl Correlates with Differentiation of Embryonal Rhabdomyosarcoma
por: Tsuchida, Rika, et al.
Publicado: (2002)

Expression of cyclin dependent kinase inhibitor p21WAF1 alone and in combination with p27KIP1 shows prognostic value in gastric carcinoma.
por: Jang, S. J., et al.
Publicado: (1998)

The expression of cyclin-dependent kinase inhibitors p15, p16, p21, and p27 during ovarian follicle growth initiation in the mouse
por: Bayrak, Aykut, et al.
Publicado: (2003)

Polo-Like Kinase 1 phosphorylates and stabilizes KLF4 to promote tumorigenesis in nasopharyngeal carcinoma
por: Mai, Jia, et al.
Publicado: (2019)

Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma
por: Hsu, Cheng-Lung, et al.
Publicado: (2018)

Knockdown of Cyclin-Dependent Kinase Inhibitor 3 Inhibits Proliferation and Invasion in Human Gastric Cancer Cells
por: Li, Yan, et al.
Publicado: (2017)

Transcriptional regulation of the cyclin-dependent kinase inhibitor 1A (p21) gene by NFI in proliferating human cells
por: Ouellet, Stéphane, et al.
Publicado: (2006)

MiR‐17‐5p promotes cancer cell proliferation and tumorigenesis in nasopharyngeal carcinoma by targeting p21
por: Chen, Chun, et al.
Publicado: (2016)

Cyclin-Dependent Kinase Inhibitor 3 Promoted Cell Proliferation by Driving Cell Cycle from G1 to S Phase in Esophageal Squamous Cell Carcinoma
por: Liu, Juan, et al.
Publicado: (2019)

Cyclin Dependent Kinase 9 Inhibitors for Cancer Therapy: Miniperspective
por: Sonawane, Yogesh A., et al.
Publicado: (2016)

Cyclin-Dependent Kinase Inhibitors Induce Apoptosis in Plant Cells
por: Strnad, M., et al.
Publicado: (2001)

Purine Inhibitors of Cyclin-Dependent Kinase and Their Apoptosis and Cytotoxicity Mechanisms
por: Strnad, M., et al.
Publicado: (2001)

Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers
por: Tavakolian, Shaian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qnajlqk06fae7iti4r354ndoga